2-aminopurine has been researched along with Hematologic Malignancies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benesch, M; Deutsch, J; Dornbusch, HJ; Kerbl, R; Kessler, HH; Lackner, H; Moser, A; Schwinger, W; Sovinz, P; Urban, C | 1 |
| Acar, K; Aki, Z; Bozdayi, G; Haznedar, R; Sucak, GT; Yağci, M | 1 |
2 trial(s) available for 2-aminopurine and Hematologic Malignancies
| Article | Year |
|---|---|
Serological and molecular response on combined antiviral treatment in children with chronic hepatitis B after pediatric malignancy.
Topics: 2-Aminopurine; Adolescent; Antiviral Agents; Child; Child, Preschool; DNA, Viral; Drug Therapy, Combination; Evaluation Studies as Topic; Famciclovir; Female; Hematologic Neoplasms; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Prednisone; Recombinant Proteins; Safety; Serotyping; Treatment Outcome | 2002 |
A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues.
Topics: 2-Aminopurine; Adult; Aged; Antineoplastic Agents; Antiviral Agents; Chronic Disease; Famciclovir; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nucleosides; Pilot Projects; Prospective Studies; Virus Activation | 2006 |